Ukuqonda i-Benign Liver Tumors
I-hematic hemangiomas (HH) yindlela exhaphakileyo yokuxhamla (noncancerous) okanye izibilini. I-tumor iqulethwe ngumnatha weemithwalo yegazi, iiseli ezihamba kuloo mijelo yegazi (i-endothelial cells), kunye nomzobo we-hepatic, osebenza njengombane oyintloko owenzela umbane. Amanye amagama kulo mzimba uquka i-hemangioma ye-cavernous okanye i-capillary hepatic hepatic.
Ngokuqhelekileyo, abantu abanolu hlobo lwesifo esihlambalayo bahlala bengenazo izibonakaliso, kwaye kuvele nje xa kwenzeka isigulane sonyango, ukuvavanywa, okanye inkqubo yonyango ehlukile.
Iingxelo ezichazwe yiNational Centre ye-Biotechnology Information (NBCI) zibonisa ukuba i-hemangiomas ye-hepatic ixhaphake ngokuqhelekileyo njenge-tumor esisodwa, nangona iindawo ezininzi zikhona. Uluhlu lwesisu lweesifo ngobukhulu obuvela kwi-2 centimeters ukuya ku-10 cm. Imizi engaphantsi kwama-2 centimeters ibonwa "encinci," kwaye ngaphezulu kwe-10 ihlelwa njengento "enkulu."
Izinto zobungozi
Okokuqala, i-hemangiomas hepatic ifunyanwe phakathi kweminyaka engama-30 ne-50 ubudala. Ukongezelela, ezi zilonda zesibindi ziba zihlandlo ezinhlanu ukuba zenzeke kubasetyhini kunamadoda. Akukho mntu uyazi ukuba kutheni izi zihlunu zikhula, kodwa abaphandi bakholelwa ukuba kunokuba nemfuza yokuzalwa, nokuba kube yimeko yokuzalwa.
Kananjalo, abanye bacinga ukuba ukukhula kwesibindi se-hemangiomas kunokuhambelana namazinga e-estrogen emzimbeni, ingakumbi ngexesha lokukhulelwa. Ngaphezu koko, ezinye iingcali zikholelwa ukuba abafazi abasebenzisa ulawulo lokuzalwa okanye ezinye iirmone zokwelapha ukunyanga ukunciphisa iimpawu zokunqamuka kwesikhashana, banokukwazi ukuphuhlisa ubunzima besibindi-nangona kubalulekile ukuqaphela ukuba akuzona zonke izicubu ezinxulumene ne-estrogen, kwaye iifom ikhule nangona kukho ukungabikho kwe-hormone.
Nangona ingcamango yokuba nesifo senqindi emzimbeni wakho inokumangalisa, abaninzi abantu baya kuhlala bengabonakali kwaye bengadingi nongenelelo lwonyango nonke.
Izimpawu kunye neMpawu
Uninzi lwexesha, akukho zibonakaliso okanye iimpawu ezihambelana ne-hematic hematic; kaninzi, ziyafumaneka xa kucinga ezinye izathu. Kodwa xa kuvela iimpawu, zingabandakanya oku kulandelayo:
Izikhalazo ezingabonakaliyo zendlela yokutya, ezinokuzifanisa ezinye izifo
Ubunzima kwi-right quadrant ephezulu yesisu (apho isibindi sifumaneka khona)
Ukunciphisa ukutya
I sizathu
Ukuvakalelwa ukuzaliseka naphezu kokutya isabelo esincinci kuphela
Ukuvutha
Ukuqhawula emva kokutya
Ezinye iimvakalelo ezingahambi kakuhle esiswini
Ihemangiomas yeHepatic ayifumanekanga xa unogqirha ugqitha okanye uhlola isisu. Ngokuxhomekeka kubukhulu kunye nommandla wesifo, iimpawu ezinzima, iimpawu kunye neengxaki ziquka:
Fever
Isibindi esandisiweyo
IAnemia
Kwiimeko ezinqabileyo, i-tumor ingakwazi ukuphazamiseka kwaye ibangele ubuhlungu obukhulu kunye nokuphaphaza ngaphakathi kwesisu.
Ukuxilongwa
Njengoko kubhalwe kwi-I- Journal of Hepatology , ezi zilandelayo iindlela ezenziwa ngayo i-hematic hepatic:
CT scan
MRI
ultrasound
Ngokuxhomekeka kwiimpawu zakho kunye nobukhulu besibindi sesibindi, umsebenzi wegazi okanye iimvavanyo ezongezelelweyo zingafuneka.
Unyango
Njengoko kuchaziwe ngaphambili, ukuba i-tumor encinci kwaye ayikunikezi naziphi na iingxaki, unyango aluyimfuneko. Kodwa ukuba ufumana ubunzima okanye ezinye iimpawu, uncedo lwezonyango luyadingeka ukuphucula imeko yakho.
Ngamanye amaxesha utyando lufuneka ukuba lususe isisu. Ukuba i-hemangioma ye hepatic ilula ukuyifumana, ugqirha unako ukhetho lokususa ubunzima kwizame zokunciphisa umonakalo kwizicubu zesibindi. Kwezinye iimeko, ugqirha unokufuneka ukuba ususe isahlulo sesibindi-esaziwa njenge-resection-ngaphezu kwe-tumor.
Ukongezelela, ugqirha unokuzama ukuvimba ukunikezelwa kwegazi kwi-tumor ngokusebenzisa inkqubo yokuhlinzwa ebizwa ngokuba yi-hepatic artery ligation okanye nge-injection ebizwa ngokuba yi-arterial embolization.
Kwiimeko ezinqabileyo, ukufakelwa kwesibindi kunokufuneka ukuba ubungakanani kunye nobubanzi be-hematic hepatic abukwazi ukulungiswa ngamanye amanyathelo. Ekugqibeleni, unyango lwe-radiation yindlela yokonyango yokunciphisa ubukhulu bomlinganiselo, kodwa ayisoloko isetyenziswa ngenxa yokukwazi ukukhokelela kwezinye iingxaki.
Prognosis
Uninzi lwabantu lunokuhlala luqhelekileyo, luphilile ubomi kunye ne-hematic hematic. Kodwa i-tumor ingaba yingxaki xa ikhula ngobukhulu okanye uhlakulele iimpawu ezenza nzima ukuhlala imihla ngemihla. Ukuba i-tumor ifunyanwe njengenxalenye yenye imeko yonyango, ugqirha unokugqiba ukukuthumela ngokujonga kwelinye ixesha kwi- gastroenterologist- ugqirha ogxininise ekuxilongweni nasekunyangeni kwimizimba yesisu kunye nezifo zesibindi.
Ukuba ufuna ukungenelela ngonyango, amathuba okuba i-tumor iya kuphinda iphantsi (nangona, kukho ambalwa amacandelo okubhaliweyo okwenzekayo). Nangona kunjalo, ukugxekwa kwexesha elide kwi-hemangiomas ye-hepatic kuthathwa njengento efanelekileyo.
Thintelo
Nangona kungekho ndlela ecacileyo yokukhusela ukukhula kwe-hematic hematic, ugqirha wakho unokuncoma indlela yokuphila yokuguqula, ukuyeka ukutshaya, ukugcina ubunzima obunempilo, ukunciphisa ukutywala kwezidakwa, nokutya ukutya okunomsoco njengezicwangciso zokuxhasa yonke impilo.
ILizwi
Nangona unokuziva uxhala malunga nokuxilongwa kwe-hematic hematic, olu hlobo luvakalelo. Ukuba ufumanisa ukuba uxhalaba kunye nokukhathazeka kukuphazamisa ukukwazi ukuhlala ubomi obupheleleyo, ungesabi ukuthetha nodokotela wakho malunga nemeko yakho. Unokufumanisa ukuba isakhono sempilo yengqondo okanye iqela lokuxhasa lingakunceda ukuba ujamelane nale meko, lungiselela ukuhlinzwa, kwaye ikuxhase emva kwenkqubo.
> Imithombo:
> Bajenaru N, Balaban V, SÄvulescu F, Campeanu I, Patrascu T. Hepatic hemangioma-ukubukela-. Umbhalo weMpilo kunye noBomi. 2015; 8 (Inkcazo ethile): 4-11.
> Evans J, Sabih DE. Hemangioma, Caverous Liver. I-website ye-NCBI StatPeals Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470283/
> Maruyama M, Isokawa O, Hoshiyama K, Hoshiyama A, Hoshiyama M, Hoshiyama Y. Ukuxilongwa noLawulo lweHemangioma enkulu yeHepatic: Ukusetyenziswa kwe-Contrast-Enhanced Ultrasonography. I-International Journal yeHepatology . 2013. Ithenda: 10.1155 / 2013/802180